0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Response to a Second Single Antihypertensive Agent Used as Monotherapy for Hypertension After Failure of the Initial Drug

Barry J. Materson, MD, MBA; Domenic J. Reda, MS; Richard A. Preston, MD; William C. Cushman, MD; Barry M. Massie, MD; Edward D. Freis, MD; Mahendr S. Kochar, MD; Robert J. Hamburger, MD; Carol Fye, RPh, MS; Raj Lakshman, PhD; John Gottdiener, MD; Eli A. Ramirez, MD; William G. Henderson, PhD; Joseph Asch, MD; Mary H. Smith, RN; Clydie Rainey; Jean Rowe; Shirley Tir; David Williams, MS; Mazen Abdellatif, MS; Barbara Lizano, MS; Dolly Koontz; Barbara Mackay; Mike R. Sather, RPh, MS; Sandra Buchanan; Claude Foy; Frances Chacon; Ibrahim Khatri, MD; Barbara Gregory, RN; Aldo Notargiacomo; Rhonda Sapp; Peter Coutlakis; Jose L. Cianchini, MD; Alba Jimenez, RN; San Juan, PR; Mike Tobin; Ann Pieczek, RN; Frederick N. Talmers, MD; Chris Grant, RN; William W. Neal, MD; Martin Henry, PA; Kalman C. Mezey, MD; Barbara Luzniak, RN; Richard E. Borreson, MD; Colleen Stewart, RN; Narain T. Srivastava, MD; Karen M. Cooper, RN; Lois Anne Katz, MD; Rosemary Mannix, RN; Stewart Nunn, MD; Anita McKnight, RN; Mahendr S. Kochar, MD, MBA; Dee Trottier, RN; Patricia Olzinski, RN; H. Mitchell Perry Jr, MD; Deborah Berg, RN; Larry Monahan, PA; Judy Politte, RN; Barry Massie, MD; Julio Tubau, MD; Elaine Der, RN; Bangshi Mukherji, MD; Marion Pannone, RN; Charlene Arnold, RN; Kathleen Fox, PA; Walter M. Kirkendall, MD; William H. Gaasch, MD; Ray W. Gifford Jr, MD; Robert F. Woolson, PhD; Daniel Deykin, MD; Ping Huang, PhD; Janet Gold
Arch Intern Med. 1995;155(16):1757-1762. doi:10.1001/archinte.1995.00430160089009.
Text Size: A A A
Published online

Background:  An important issue in clinical practice is how to treat patients whose blood pressure does not respond to the first antihypertensive drug selected.

Objective:  To analyze the antihypertensive response of patients who had failed to achieve their diastolic blood pressure goal (<90 mm Hg at the end of 8 to 12 weeks of titration) with one of six randomly allocated drugs or placebo to the random allocation of an alternate drug.

Methods:  We initially randomized 1292 men with diastolic blood pressure of 95 to 109 mm Hg to treatment with hydrochlorothiazide, atenolol, captopril, clonidine hydrochloride, diltiazem hydrochloride (sustained release), prazosin hydrochloride, or placebo. Of 410 men in whom initial treatment failed, 352 qualified for randomization to the alternate drug.

Results:  Of the 352 patients, 173 (49.1%) achieved their goal diastolic blood pressure, in 133 (37.8%) the alternate drug failed, and 46 (13.1%) left the study for various reasons. Overall response rates were as follows: diltiazem, 63%; clonidine, 59%; prazosin, 47%; hydrochlorothiazide, 46%; atenolol, 41%; and captopril, 37%. The best response rate for patients in whom hydrochlorothiazide failed was achieved with diltiazem (70%); after atenolol failure, clonidine (86%); after captopril failure, prazosin (54%); after clonidine failure, diltiazem (100%); after diltiazem failure, captopril (67%); and after prazosin failure, clonidine (53%). The combined response rate for patients initially randomized to an active treatment was 76.0%, which is similar to that achieved by the combination of two drugs in previous studies.

Conclusions:  We conclude that sequential single-drug therapy is a rational approach for treatment of hypertension in patients in whom initial drug therapy has failed.(Arch Intern Med. 1995;155:1757-1762)

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 33

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();